Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tubulin beta class I pseudogene 6 (TUBBP6) is a pseudogene located on chromosome 7 (chr7:55645620-55646951, hg38)[5][1]. As a pseudogene, it is a non-functional DNA segment resembling the functional beta-tubulin gene (TUBB). Pseudogenes do not code for active, functional proteins and do not have established biological roles, therapeutic relevance, or direct disease linkage. TUBBP6 does not produce a protein, is not a validated drug target, and has no associated pharmacological or biomarker relevance[1][5]. Additional context: - Pseudogene Definition: Pseudogenes are genomic sequences similar to normal genes but typically non-functional due to mutations, frameshifts, or lack of regulatory elements required for gene expression. - Distinguishing from Functional Beta-Tubulin: The functional gene TUBB encodes a component of microtubules important for cell structure and division, and is a bona fide target with disease associations[3][7]. TUBBP6 is only one of several pseudogenes for this functional locus[3]. Summary of appropriateness as a target: - TUBBP6 is not considered a therapeutic target. It is a pseudogene with no known protein product, biological activity, drug interaction, or disease relevance. Its primary value is in genomic annotation, and not as a molecular target for interventions[1][5]. Notes on possible confusion: - The query is not a misspelling but is not a valid target for drug discovery, biological function, or disease mechanism studies. For research on microtubule-associated processes or tubulin-targeting agents, the functional gene TUBB or related family members should be referenced[3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tubulin beta class I pseudogene 6 (TUBBP6).